Agios Pharmaceuticals, Inc.

AGIO

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001439222

SEC filings (opens in a new tab)

In the last 90 days, Agios Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 1 sale; 238 institutions reported holding it in 13F filings for Q2 2026, worth $2.45B in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Agios Pharmaceuticals, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024 All holders in Q1 2024

13F holders of AGIO: Q1 2024 compared with Q2 2024
Measure	Q1 2024	Of which not filed for Q2 2024	Q2 2024	Change
Holders	187	2	206	+21
Shares	62.0M	118.8K	58.1M	−3.74M (−6.0%)
Value	$1.81B	$3.47M	$2.51B	+$698.2M (+38.6%)

2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (48)

Institutions that held Agios Pharmaceuticals, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to AGIO in Q2 2024
Institution	Shares	Value	% of portfolio
BVF Inc	1,190,107	$51.3M	1.44%
Schonfeld Strategic Advisors LLC	464,121	$20.0M	0.16%
Loomis Sayles & Co L P	448,863	$19.4M	0.03%
Parkman Healthcare Partners LLC	446,416	$19.2M	2.62%
Candriam Luxembourg S.C.A.	322,882	$13.9M	0.08%
Artisan Partners Limited Partnership	320,467	$13.8M	0.02%
CenterBook Partners LP	249,311	$10.8M	0.67%
Panagora Asset Management Inc	174,870	$7.54M	0.04%
Granahan Investment Management Inc	136,838	$5.90M	0.24%
First Trust Advisors LP	130,411	$5.62M	0.01%
Woodline Partners LP	113,378	$4.89M	0.05%
EAM Investors, LLC	74,142	$3.20M	0.52%
Moore Capital Management, LP	60,000	$2.59M	0.06%
Edgestream Partners, L.P.	42,076	$1.81M	0.09%
Seven Eight Capital, LP	39,262	$1.69M	0.18%
Connor, Clark & Lunn Investment Management Ltd.	37,281	$1.61M	0.01%
Mirae Asset Global ETFs Holdings Ltd.	36,140	$1.56M	0.00%
Corebridge Financial, Inc.	30,406	$1.31M	0.01%
Y-Intercept (Hong Kong) Ltd	25,945	$1.12M	0.06%
SEI Investments Co	23,378	$1.01M	0.00%
Scientech Research LLC	17,592	$758.6K	0.16%
Nomura Holdings Inc	12,106	$522.0K	0.00%
Headlands Technologies LLC	11,450	$493.7K	0.05%
Group One Trading, L.P.	10,103	$435.6K	0.01%
Aquatic Capital Management LLC	8,800	$379.5K	0.01%
Atria Investments LLC	7,210	$310.9K	0.00%
Gallagher Fiduciary Advisors, LLC	6,940	$299.3K	0.07%
Fox Run Management, L.L.C.	6,818	$294.0K	0.06%
Commerce Bank	6,239	$269.0K	0.00%
Northcape Wealth Management, LLC	5,670	$244.5K	0.09%
XTX Topco Ltd	5,333	$230.0K	0.02%
North Star Asset Management Inc	5,000	$215.6K	0.01%
Bridgefront Capital, LLC	4,965	$214.1K	0.09%
Virtu Financial LLC	4,960	$214.0K	0.01%
KBC Group NV	2,004	$86.0K	0.00%
State of Wyoming	1,136	$49.0K	0.01%
STRS Ohio	1,100	$47.4K	0.00%
Quest Partners LLC	919	$39.6K	0.01%
Acadian Asset Management LLC	864	$37.0K	0.00%
Parallel Advisors, LLC	492	$21.2K	0.00%
Sunbelt Securities, Inc.	225	$9.70K	0.00%
Hillsdale Investment Management Inc.	200	$8.62K	0.00%
Smartleaf Asset Management LLC	86	$3.75K	0.00%
Stephens Consulting, LLC	55	$2.37K	0.00%
Twin Tree Management, LP	52	$2.24K	0.00%
Mather Group, LLC.	55	$1.61K	0.00%
Innealta Capital, LLC	17	$733	0.00%
CVA Family Office, LLC	15	$647	0.00%

Sold out (27)

Institutions that held Agios Pharmaceuticals, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of AGIO in Q2 2024
Institution	Shares, Q1 2024	Value, Q1 2024
T. Rowe Price Investment Management, Inc.	928,596	$27.2M
Paradigm Biocapital Advisors LP	400,000	$11.7M
Vestal Point Capital, LP	325,000	$9.50M
Cutter Capital Management, LP	288,580	$8.44M
Two Sigma Investments, LP	122,282	$3.58M
Altitude Crest Partners Inc.	113,100	$3.31M
ExodusPoint Capital Management, LP	101,612	$2.97M
Exome Asset Management LLC	59,902	$1.75M
Parallax Volatility Advisers, L.P.	48,434	$1.42M
Tudor Investment Corp Et Al	35,734	$1.04M
Nebula Research & Development LLC	34,855	$1.02M
Gsa Capital Partners LLP	30,853	$902.0K
American International Group, Inc.	27,375	$800.4K
Prosight Management, LP	25,000	$731.0K
Schroder Investment Management Group	24,000	$701.8K
Two Sigma Advisers, LP	20,900	$611.1K
Deerfield Management Company, L.P. (Series C)	17,658	$516.3K
Prelude Capital Management, LLC	15,056	$440.2K
Renaissance Technologies LLC	14,714	$430.0K
Entropy Technologies, LP	9,787	$286.2K
Royce & Associates LP	7,338	$214.6K
Metropolitan Life Insurance Co	2,956	$86.4K
EntryPoint Capital, LLC	2,924	$85.5K
North Star Investment Management Corp.	125	$3.65K
SYSTM Wealth Solutions LLC	35	$1.02K
Nelson, Van Denburg & Campbell Wealth Management Group, LLC	11	$321
Principal Securities, Inc.	10	$292

Not filed for Q2 2024 yet (2)

Institutions that held Agios Pharmaceuticals, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AGIO in Q1 2024 that haven't filed for Q2 2024
Institution	Shares, Q1 2024	Value, Q1 2024
Credit Suisse AG	111,632	$3.26M
Cutler Group LP	7,130	$208.0K